Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease

Medical Hypotheses
|November 26, 2015
PubMed

Insights

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may be an infectious disease. Evidence suggests a persistent pathogen, transmission, and carrier states, necessitating pathogen identification for diagnosis and treatment.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Epidemiology

Background:

  • Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) etiology remains unestablished, with ongoing debate regarding its organic versus psychological nature.
  • Previous hypotheses included psychosomatic disorders, infections, immune dysfunction, autoimmunity, metabolic issues, toxins, and genetic factors.
  • The existence of ME/CFS as a distinct disease entity is sometimes contested.

Purpose of the Study:

  • To evaluate the hypothesis that ME/CFS is an infectious disease caused by a persistent pathogen.
  • To explore evidence supporting pathogen transmission, host susceptibility, and carrier states in ME/CFS.
  • To identify research directions for confirming the infectious etiology and developing diagnostic and therapeutic strategies.

Main Methods:

  • Review of clinical, immunological, and epidemiological evidence related to ME/CFS.
  • Analysis of outbreak data, patient-contact studies, and immune responses in sporadic cases.
  • Examination of risk factors and potential transmission routes.

Main Results:

  • Clinical and immunological data align with an infectious disease model, including flu-like onset and immune responses similar to other infections.
  • Epidemiological findings suggest contagion through casual contact and increased prevalence in close contacts.
  • Evidence supports the existence of persistent pathogens, carrier states, and host factors influencing susceptibility.

Conclusions:

  • Clinical, immunological, and epidemiological evidence strongly supports ME/CFS being an infectious disease caused by a persistent pathogen.
  • Identification of the causal pathogen is crucial for diagnosis, biomarker development, antimicrobial treatments, and preventive measures.
  • Further research should focus on identifying both known and unknown pathogens to validate the hypothesis and advance patient care.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
445
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.9K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.4K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.5K